Trial intelligence / Profile preview

Rasagiline for Fatigue in Parkinson's Disease (REST)

NCT01168596Phase 4Completed

Sponsor
University of Florida
Start
Dec 2009
Primary completion
May 2012
Modality
Irreversible Covalent Inhibitors
Countries
1
01

Overview

A Phase 4 trial of rasagiline in Parkinson's disease (PD), sponsored by University of Florida. Started Dec 2009; status: completed.

02

Drugs

rasagiline
03

Conditions

Parkinson's disease (PD)

Beyond the preview

Go deeper on NCT01168596.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01168596.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call